XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.4
Borrowings
 12 Months Ended
Jun. 30, 2025
Schedule Of Borrowings  
Borrowings

 

15. Borrowings

 

   2025   2025   2024 
   US$   S$   S$ 
             
Current:               
- Bank overdraft   48,251    61,371    - 
- Lease liabilities   1,619,426    2,059,748    28,500 
- Bank borrowings   -    -    2,677,856 
Borrowings Current   1,667,677    2,121,119    2,706,356 
                
Non-current:               
- Lease liabilities   2,324,654    2,956,727    - 
- Bank borrowings   -    -    1,583,434 
Borrowings Non-Current   2,324,654    2,956,727    1,583,434 
Borrowings   3,992,331    5,077,846    4,289,790 

 

The breakdown of borrowings are as follows:

 

 Schedule of breakdown borrowings

   2025   2025   2024 
   US$   S$   S$ 
             
Term loan #1            -           -    206,695 
Term loan #2   -    -    280,233 
Term loan #3   -    -    178,565 
Term loan #4   -    -    195,299 
Term loan #6   -    -    531,708 
Term loan #7   -    -    280,239 
Term loan #9   -    -    322,818 
Term loan #10   -    -    1,573,744 
Term loan #11   -    -    691,989 
Term loan #12   -    -    - 
Term loan   -    -    4,261,290 

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

15. Borrowings (Continued)

 

The details of borrowings are as follows:

 

 Schedule of details borrowings

Term loan 

Facility

amount

 

Effective

interest rate

   Maturity date
       % p.a.    
            
Term loan #1  S$600,000   2.50%  October 2025
Term loan #2  S$1,000,000   2.75%  October 2025
Term loan #3  S$600,000   2.75%  November 2025
Term loan #4  S$700,000   2.50%  November 2025
Term loan #6  S$1,400,000   2.25%  April 2026
Term loan #7  S$1,000,000   2.75%  October 2025
Term loan #9  S$850,000   2.25%  April 2026
Term loan #10  S$600,000   2.75%  November 2025
   S$1,000,000   3.00%  November 2025
   S$500,000   2.50%  March 2026
   S$529,890   1.53%  December 2035
   S$501,670   1.53%  December 2035
Term loan #11  S$400,000   2.25%  January 2026
   S$1,500,000   2.50%  December 2025
Term loan #12  S$4,000,000   4.30%  One-month term, upon maturity

 

Term loan #1 to #12 was fully settled during the financial year, and as at June 30, 2025, there are no outstanding bank borrowings.

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

15. Borrowings (Continued)

 

A reconciliation of liabilities arising from financing activities is as follows:

 

 Schedule of reconciliation of liabilities arising from financing activities

  

Beginning of

       Proceed from   Non-cash changes    Fair    End of 
  

financial
year

   Cash flows  

bank

borrowings

  

 Addition

  

Accretion of

interests

   Other   

value

reserve

   

financial

year

 
    US$    US$    US$    US$    US$    US$      US$     US$ 
                                            
June 30, 2025                                           
Liabilities                                           
Bank overdraft   

-

    

-

    

48,251

    -    -    -      -     

48,251

Lease liabilities                                           
- Current   22,407    (861,945)   -    3,557,047    90,389    (1,188,472)     -     1,619,426 
- Non-current   -    -    -    -    -    39,380      2,285,274     2,324,654 
Bank borrowings                                           
- Current   2,105,398    (5,320,259)   3,144,901    -    69,960    -      -     - 
- Non-current   1,244,936    (1,244,936)   -    -    -    -      -     - 
                                            
    3,372,741    (7,427,140)   3,193,152    3,557,047    160,349    (1,149,092)     2,285,274     3,992,331 

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024

 

15. Borrowings (Continued)

 

  

Beginning of

       Proceed from   Non-cash changes    Fair    End of 
  

financial
year

   Cash flows  

bank

borrowings

   Addition  

Accretion of

interests

   Other    value reserve    financial
year		 
   S$   S$   S$   S$   S$   S$    S$    S$ 
                                     
June 30, 2025                                           
Liabilities                                                                
Bank overdraft   

-

    -    61,371    

-

    -    -      -     

61,371

 
Lease liabilities                                           
- Current   28,500    (1,096,308)   -    4,524,209    114,966    (1,511,619)     -     2,059,748 
- Non-current   -    -    -    -    -    50,087      2,906,640     2,956,727 
Bank borrowings                                           
- Current   2,677,856    (6,766,838)   4,000,000    -    88,982    -      -     - 
- Non-current   1,583,434    (1,583,434)   -    -    -    -            - 
                                            
    4,289,790    (9,446,580)   4,061,371    4,524,209    203,948    (1,461,532)     2,906,640     5,077,846 
                                            
June 30, 2024                                           
Liabilities                                           
Lease liabilities                                           
- Current   566,039    (553,000)   -    -    15,461    -      -     28,500 
- Non-current   28,500    -    -    -    -    (28,500)     -     - 
Bank borrowings                                           
- Current   3,223,150    (2,517,707)   -    -    160,777    1,811,636      -     2,677,856 
- Non-current   3,395,070    -    -    -    -    (1,811,636)     -     1,583,434 
                                            
    7,212,759    (3,070,707)   -    -    176,238    (28,500)     -     4,289,790 

 

 

Basel Medical Group Ltd. and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For year ended June 30, 2025 and 2024